Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 12.9514.1218.0952.1222.82

What is the latest Core EBITDA Margin ratio of LYKA LABS ?

The latest Core EBITDA Margin ratio of LYKA LABS is 12.95 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202512.95
Mar202414.12
Mar202318.09
Mar202252.12
Mar202122.82

How is Core EBITDA Margin of LYKA LABS Trending?

Years Core EBITDA Margin % Change
Mar2025 12.95
-8.29
Mar2024 14.12
-21.95
Mar2023 18.09
-65.29
Mar2022 52.12
128.40
Mar2021 22.82 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Margin ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹356.5 Cr -4.9% -11.1% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-4.9%

-11.1%

-17.5%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses